| Cindy Nguyen, PHARMD | |
|
13651 Havenwood Dr, Garden Grove, CA 92843-3507 | |
| (714) 210-9530 | |
| Not Available |
| Full Name | Cindy Nguyen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 13651 Havenwood Dr, Garden Grove, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447913546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 85235 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cindy Nguyen, PHARMD 13651 Havenwood Dr, Garden Grove, CA 92843-3507 Ph: (714) 210-9530 | Cindy Nguyen, PHARMD 13651 Havenwood Dr, Garden Grove, CA 92843-3507 Ph: (714) 210-9530 |
News Archive
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, responded to the Bard Peripheral Vascular, Inc. lawsuit filed against Endologix in the United States District Court of Arizona. The Bard Peripheral lawsuit alleges that Endologix's proprietary high density ePTFE graft material, which is used for the Powerlink® System, infringes on Bard Peripheral's "Prosthetic Vascular Graft" patent (U.S. Patent No. 6,436,135).
As prostate cancer is the third leading cause of cancer death in European men with more than 300,000 men being diagnosed every year, society needs to commit to changing the way the disease is viewed. Therefore a mini-symposium and lunch meeting are organized on 18 September 2009 in Antwerp on the occasion of the European launch of the Proactive Prostates Initiative, organized as part of Urology Week.
Researchers at the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less than 48 hours. The method, called SARSeq, is published in the journal Nature Communications and could be adapted to many more pathogens.
CEFALY Technology announced today that its received U.S. Food and Drug Administration approval of the Cefaly medical device for the preventative treatment for migraine headaches. Cefaly is the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use prior to the onset of pain. It is expected to be available in the U.S. in early April.
A simple balance test may predict cognitive decline in Alzheimer's Disease, according to a study published in the March 2009 issue of the Journal of Alzheimer's Disease.
› Verified 8 days ago
Tram Ngoc-celia Nguyen, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14384 Brookhurst St, Garden Grove, CA 92843 Phone: 714-531-1740 Fax: 714-531-9624 | |
Ngoc Le, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13822 Brookhurst St, Garden Grove, CA 92843 Phone: 714-530-3136 | |
Karen Liu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12001 Euclid St, Garden Grove, CA 92840 Phone: 714-530-1071 | |
Dr. Michael Thantron, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12491 Valley View St, Garden Grove, CA 92845 Phone: 714-894-9230 | |
Tuan La, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10596 Garden Grove Blvd, Garden Grove, CA 92843 Phone: 714-462-4480 Fax: 714-462-4490 | |
Soufya Zohreh-kermany, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12001 Euclid St, Garden Grove, CA 92840 Phone: 714-530-1071 | |
Nina Hoang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7373 Lincoln Way, Garden Grove, CA 92841 Phone: 800-228-3643 |